PharmaShots | Incisive News in 3 Shots

Subscribe Now

Plasminogen Deficiency

ProMetic' Ryplazim (plasminogen) Receives the US FDA's Approval as First Treatment for Patients with Plasminogen Deficiency

ProMetic' Ryplazim (plasminogen) Receives the US FDA's Approval as First Treatment for Patients with Plasminogen Deficiency

June 7, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us